ERK5 was found to associate with actin and cofilin in the cytosol in TNBC breast cancer cells, whereas ERK5 interacted with estrogen receptor (ER)-α in the nucleus in ER-positive breast cancer to increase cell invasion [61]. Here, ESR1 is linked to breast cancer.